2 companies
UCB
Market Cap: €50.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€263.10
7D
-2.4%
1Y
34.5%
argenx
Market Cap: €39.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€642.40
7D
-9.5%
1Y
8.5%